Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9467 publications

Clinical study on induction chemotherapy combined with concurrent chemoradiotherapy for oropharyngeal squamous cell carcinoma

Clinical study on induction chemotherapy combined with concurrent chemoradiotherapy for oropharyngeal squamous cell carcinoma

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: December 10, 2025

BREAKWATER Phase III: results for encorafenib and cetuximab plus mFOLFOX6 in first-line BRAF V600E-mutant metastatic colorectal cancer.

BREAKWATER Phase III: results for encorafenib and cetuximab plus mFOLFOX6 in first-line BRAF V600E-mutant metastatic colorectal cancer.

Journal: Future oncology (London, England)
Published: November 13, 2025

Emerging and Investigational Systemic Therapies in Recurrent/Metastatic Head and Neck Cancer After Progression on Immunotherapy.

Emerging and Investigational Systemic Therapies in Recurrent/Metastatic Head and Neck Cancer After Progression on Immunotherapy.

Journal: Cancers
Published: October 29, 2025

A Case of MSI‒Stable Rectal Cancer with Para‒Aortic Lymph Node Metastasis Treated by Sequential Therapy with Standard Treatment and Immune Checkpoint Inhibitors

A Case of MSI‒Stable Rectal Cancer with Para‒Aortic Lymph Node Metastasis Treated by Sequential Therapy with Standard Treatment and Immune Checkpoint Inhibitors

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 27, 2025

Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial).

Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial).

Journal: Diagnostics (Basel, Switzerland)
Published: October 24, 2025

Closing the loop on EGFR therapy: decoding cetuximab response through circ-EGFR.

Closing the loop on EGFR therapy: decoding cetuximab response through circ-EGFR.

Journal: EMBO molecular medicine
Published: October 10, 2025

Durable complete response to tislelizumab plus cetuximab in a 94-year-old patient with advanced lower lip squamous cell carcinoma: A case report and literature review.

Durable complete response to tislelizumab plus cetuximab in a 94-year-old patient with advanced lower lip squamous cell carcinoma: A case report and literature review.

Journal: Oral oncology
Published: October 08, 2025

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

Journal: Otolaryngologic clinics of North America
Published: October 04, 2025

Targeted Therapies in Oral and Oropharyngeal Cancer: An Overview of Emerging and Repurposed Agents.

Targeted Therapies in Oral and Oropharyngeal Cancer: An Overview of Emerging and Repurposed Agents.

Journal: Cancers
Published: October 01, 2025

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

Prediction of Severe Skin Disorders Induced by Anti-epidermal Growth Factor Receptor Antibody Drugs

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: October 01, 2025

Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies.

Journal: Tumor discovery
Published: September 29, 2025

Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Journal: Magnesium research
Published: September 26, 2025
Showing 1-12 of 9,467

Last Updated: 01/07/2026